In response to dosing omalizumab in allergic asthma
- 1 January 2007
- journal article
- other
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 119 (1), 255-256
- https://doi.org/10.1016/j.jaci.2006.10.026
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Omalizumab dosing via the recommended card versus use of the published formulaJournal of Allergy and Clinical Immunology, 2006
- Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthmaClinical and Experimental Allergy, 2004
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsEuropean Respiratory Journal, 2001